@IQ_Needle
Helping You Do No Harm
For Children with Acute Lymphoblastic Leukemia
Injeq IQ-Needle™ helps you to avoid unnecessary needle movements for the benefit of the patient.
Acute lymphoblastic leukemia (ALL) is the most common cancer type diagnosed in children. During the treatment, which usually lasts around 30 months, approximately 20 lumbar punctures (spinal taps) are performed on the patient.
As the tip of the needle must be precisely inserted into the spinal canal, each of the punctures is a challenging procedure. At the same time, you have to be careful not to insert the needle even slightly too far, because there is a risk of bleeding that allows cancer cells to enter the spinal canal, lowering the chances of recovery.
The smart digital technology in Injeq IQ-Needle reduces the risk of bleeding. It protects the patient and helps you to get uncontaminated spinal fluid samples.
When you know, at all times, where the tip of the needle is, you are able to avoid unnecessary needle movements near the spinal nerves. Thus the smart IQ-Needle also allows performing more punctures without anesthesia.
For Diagnosing Neonatal Meningitis
Working in ER, the pressure for fast diagnoses is high 24 hours a day, and sometimes you have to make quick calls.
When you have a patient with suspected neonatal meningitis, it is imperative to get a quick CSF sample for a diagnosis. Although it is an established and simple procedure in theory, performing a lumbar puncture to a child while under pressure is not completely without risk.
The puncture still has to be performed for the sake of the little patient, because undiagnosed meningitis is always a life-threatening condition.
According to surveys, 24–40% of punctures performed on newborn babies fail or result in tissue damage. In addition to pain, failed punctures cause delays, poor-quality samples, and further expenses, as the patient may have to spend more time in intensive care.
Injeq IQ-Needle™ allows less stylet removals and reinsertions, and smoother and faster punctures with a better success rate. Less uncertainty for you and more comfort for the baby, with less expensive time in the unit.
Care at the Tip of the Needle
20
Lumbar Punctures
Treatment for ALL-type leukemia requires several lumbar punctures, usually around 20 per patient. Performing every single one of them successfully is important.
200
Measurements/Second
When performing a lumbar puncture, approaching the spinal canal carefully is paramount. Injeq IQ-NeedleTM measures 200 times per second whether you have reached the canal, and gives you an audio alarm when the tip of the needle is there.
–2700€
/Day
A delayed diagnosis puts the patient at risk, and it may also cost a lot of money. Keeping a child in intensive care costs potentially 2700 euros a day. That is why you want the confidence to perform the needed procedure immediately.
Better Treatment with Pioneering Technology
Injeq IQ-Needle™
Injeq IQ-Needle is based on ten years of innovation, research, and field studies – not to mention top medical expertise and a supporting attitude toward those performing and receiving lumbar puncture procedures.
Pioneering tissue identification technology provides precise real-time information on tissue composition, helping you to avoid unnecessary needle movements, reduce the risk of contaminated spinal fluid samples and the risk of bleeding, that may lower the chances of recovery in treating cancer. Using IQ-Needle also enables performing more punctures without anesthesia.
Know Exactly Where the Tip Is
IQ-Needle eases your work by telling you when the spinal fluid has been reached via an audio alarm. You will know exactly where the tip of the smart needle is, and when it has reached the spinal canal. It doesn’t matter if you are a seasoned medical professional or straight out of medical school, IQ-Needle gives you more accuracy and confidence in performing a lumbar puncture.
With Injeq IQ-Needle it is possible to get the puncture right the first time, every time.
Because Every Procedure Matters
The smart needle helps you to avoid unnecessary needle movements and reduce the risk of poor-quality samples and bleeding.
IQ-Needle™ enables performing more punctures without anesthesia.
Smoother and faster punctures with better success rates ease the discomfort of the patient and save time and money.
Future uses include for example cancer diagnoses, tumor biopsies, and administering drugs and injections.
Behind The Smart and Caring Needle
Injeq Ltd.
Injeq was founded when a group of experts in the fields of technology and medicine identified a solution for a well-known medical need – to make lumbar punctures safer and more precise. The vision of a smart needle developed to a fully-formed idea, and from there to clinical research at neonatal intensive care units.
Now Injeq has a clinically proven product ready for the market, based on unique, tried and tested technology. Injeq IQ-NeedleTM is the leading product in its field, offering safer, faster, and smoother procedures through real-time information.
Our staff consists of professionals with expertise in a wide range of fields, including medical research, signal processing, clinical research, European regulation, and various areas of production, quality assurance, and corporate management.
We have an active corporate board, that includes the original developers of the innovation and outside experts. The board members support the operational organization and participate actively in the development of Injeq.
The main benefits of our smart needle – precision, care, and confidence – are present in everything that we do and what we want to offer our clients.
